Sunday, October 6, 2024

Search Results

Dialectic Therapeutics Announces DT2216 Has Received Orphan Drug Designation from the FDA for the Treatment of T-Cell Lymphoma

Dialectic Therapeutics, Inc., a Texas-based clinical stage biotechnology company focused on creating innovative new technologies to treat cancer, announced that the U.S. Food and...

New Portal for Pharmaceutical Industry Data and Research Reports

Industry Standard Research, a full-service pharmaceutical market research company with over 15 years of industry experience, has partnered with specialist technology provider Content Catalyst...

cleverbridge Halts Operations in Russia and Belarus

cleverbridge, a front runner in global commerce and subscription billing for B2B and B2C organizations, will cease business activities in Russia and Belarus immediately. Also...

Orgain Brings “That Winning Feeling” to College Hoops

Orgain, the leader in high-quality, delicious-tasting clean nutrition is bringing “That Orgain Feeling” to women’s college basketball this season. Throughout the tournament, Orgain will...

Specialty Enzymes & Probiotics is Proud to Announce That the FDA has Granted GRAS No Objection Letter for SEBclausii

The GRAS Notification Program is a voluntary submission for products intended as food additives. Based on our extensive research, specifications, intended usage, history, preparation,...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics